Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra in Still's Disease
NCT03265132Phase 3Terminated
- Sponsor
- Sobi
- Start
- Sep 2017
- Primary completion
- Feb 2019
- Modality
- Cytokines & Interferons
- Countries
- 2
01
Overview
A Phase 3 trial of anakinra in adult-onset Still's disease (AOSD), sponsored by Sobi. Started Sep 2017; status: terminated.
02
Drugs
anakinra
03
Conditions
adult-onset Still's disease (AOSD)
Beyond the preview
Go deeper on NCT03265132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03265132.